Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
Xiaolei Liu, Anurag Verma, Gustavo Garcia, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 42
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 405
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Wenbing Wu, Ying Cheng, Hong Zhou, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 140
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
Bryan A. Johnson, Yiyang Zhou, Kumari G. Lokugamage, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010627-e1010627
Open Access | Times Cited: 129
Phase separation by the SARS-CoV-2 nucleocapsid protein: Consensus and open questions
Sean M. Cascarina, Eric D. Ross
Journal of Biological Chemistry (2022) Vol. 298, Iss. 3, pp. 101677-101677
Open Access | Times Cited: 71
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication
Tomer M. Yaron, Brook E. Heaton, Tyler Levy, et al.
Science Signaling (2022) Vol. 15, Iss. 757
Open Access | Times Cited: 52
Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation
Wenbiao Wang, Junzhe Chen, Xueqing Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4704-4713
Open Access | Times Cited: 49
SARS-CoV-2 Nucleocapsid Protein Targets a Conserved Surface Groove of the NTF2-like Domain of G3BP1
Mahamaya Biswal, Jiuwei Lu, Jikui Song
Journal of Molecular Biology (2022) Vol. 434, Iss. 9, pp. 167516-167516
Open Access | Times Cited: 38
Molecular mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients
Mohsen Karami Fath, Malihe Naderi, Hosna Hamzavi, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 73, pp. 127044-127044
Open Access | Times Cited: 38
Assembly of SARS-CoV-2 nucleocapsid protein with nucleic acid
Huaying Zhao, Abdullah M. Syed, Mir M. Khalid, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 11, pp. 6647-6661
Open Access | Times Cited: 9
Reconstitution of the SARS-CoV-2 ribonucleosome provides insights into genomic RNA packaging and regulation by phosphorylation
Christopher R. Carlson, Armin N. Adly, Maxine Bi, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 11, pp. 102560-102560
Open Access | Times Cited: 37
Classification, replication, and transcription of Nidovirales
Ying Liao, Huan Wang, Huiyu Liao, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
A specific phosphorylation-dependent conformational switch of SARS-CoV-2 nucleoprotein inhibits RNA binding
Maiia Botova, Aldo R. Camacho‐Zarco, Jacqueline Tognetti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern
Luca Murer, Romain Volle, Vardan Andriasyan, et al.
Current Research in Virological Science (2022) Vol. 3, pp. 100019-100019
Open Access | Times Cited: 26
Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug
Bo Zhang, Junjie Tian, Qintao Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 25
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein
Xiafei Wei, Yuzheng Zhou, Xiaotong Shen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2505-2519
Open Access | Times Cited: 5
SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway
Shigeru Yamada, Tadahiro Hashita, Shota Yanagida, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
A specific phosphorylation-dependent conformational switch in SARS-CoV-2 nucleocapsid protein inhibits RNA binding
Maiia Botova, Aldo R. Camacho‐Zarco, Jacqueline Tognetti, et al.
Science Advances (2024) Vol. 10, Iss. 31
Open Access | Times Cited: 5
Flavivirus NS1 Triggers Tissue-Specific Disassembly of Intercellular Junctions Leading to Barrier Dysfunction and Vascular Leak in a GSK-3β-Dependent Manner
Henry Puerta‐Guardo, Scott B. Biering, Francielle Tramontini Gomes de Sousa, et al.
Pathogens (2022) Vol. 11, Iss. 6, pp. 615-615
Open Access | Times Cited: 22
Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis
Giovanna Fico, Ulker Isayeva, Michele De Prisco, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 30-44
Open Access | Times Cited: 19
Human 14-3-3 Proteins Site-selectively Bind the Mutational Hotspot Region of SARS-CoV-2 Nucleoprotein Modulating its Phosphoregulation
Kristina V. Tugaeva, Andrey A. Sysoev, Anna A. Kapitonova, et al.
Journal of Molecular Biology (2022) Vol. 435, Iss. 2, pp. 167891-167891
Open Access | Times Cited: 19
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis
Junji Zhu, Guanqun Liu, Zuberwasim Sayyad, et al.
Journal of Virology (2024) Vol. 98, Iss. 9
Open Access | Times Cited: 4
Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons
Fiona Limanaqi, Silvia Zecchini, Borana Dino, et al.
Cells (2022) Vol. 11, Iss. 10, pp. 1691-1691
Open Access | Times Cited: 17
Contributions of the N‐terminal intrinsically disordered region of the severe acute respiratory syndrome coronavirus 2 nucleocapsid protein to RNA‐induced phase separation
Milan Zachrdla, Adriana Savastano, Alain Ibáñez de Opakua, et al.
Protein Science (2022) Vol. 31, Iss. 9
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top